Researchers explore TAF1's role in leukemia, revealing potential targeted therapies that could transform treatment approaches ...

Scientists have discovered that rogue DNA rings, called extrachromosomal DNA (ecDNA), appear early in glioblastoma and drive its rapid growth and resistance to therapy.

Silexion Therapeutics ( ($SLXN) ) has issued an announcement. On September 11, 2025, Silexion Therapeutics announced positive preclinical data for ...

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of ...

Perioperative therapy has become a critical component in the management of resectable non–small cell lung cancer (NSCLC), particularly in the era of precision medicine. Although molecular testing is ...

The FDA granted two fast track designations to TT125-802, an investigational therapy, for the treatment of ...

Extrachromosomal DNAs (ecDNAs) are circular DNA structures located in the nuclei of cells outside chromosomes. They were originally discovered in chromosome spreads of cells obtained from embryonal ...

Cancer is the leading cause of disease-related death in childhood. This is in part due to cancer-associated genes called oncogenes that can be found far from chromosomes in cell nuclei on ring-shaped ...